Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 1 de 1
Filtre
Ajouter des filtres








Gamme d'année
1.
Braz. j. med. biol. res ; 27(3): 737-41, Mar. 1994. graf
Article Dans Anglais | LILACS | ID: lil-148948

Résumé

Fencamfamine (FCF) is a psychostimulant drug classified as an indirect dopamine agonist. In the present study we evaluated the daily variation in plasma FCF concentration and in striatal dopamine receptors. Adult male Wistar rats (250-300 g) maintained on a 12-h light/12-h dark cycle (lights on at 07:00 h) were used. Rats received FCF (10.0 mg/kg, ip) at 09:00, 15:00, 21:00 or 03:00 h and blood samples were collected 30 (N = 6) or 60 (N = 6) min after the injections. Plasma FCF was measured by gas chromatography using an electron capture detector. Two-way ANOVA showed significant differences in FCF concentration when blood samples were collected 30 min after the injection, and the highest value was obtained following injection at 21:00 h. Moreover, at 15:00, 21:00 and 03:00 h, plasma FCF levels were significantly lower 60 min after injection when compared to the 30-min interval. Two other groups of rats (N = 6) were decapitated at 09:00 or 21:00 h and the striata were dissected for the binding assays. The Bmax for [3H]-spiroperidol binding to striatal membranes was higher at 21:00 h, without changes in affinity constant (Kd). In conclusion, plasma FCF levels and dopamine receptors undergo daily variation, a phenomenon that should be considered to explain the circadian time-dependent effects of FCF


Sujets)
Animaux , Mâle , Rats , Rythme circadien , Monoterpènes de type norbornane/sang , Récepteurs dopaminergiques/métabolisme , Acide homovanillique/métabolisme , Chromatographie en phase gazeuse , Rythme circadien/effets des médicaments et des substances chimiques , Corps strié/effets des médicaments et des substances chimiques , Corps strié/métabolisme , Injections péritoneales , Monoterpènes de type norbornane/administration et posologie , Monoterpènes de type norbornane/pharmacologie , Rat Wistar , Spipérone/métabolisme , Facteurs temps
SÉLECTION CITATIONS
Détails de la recherche